Mead Johnson Nutrition
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Mead Johnson Nutrition's revenues will increase 4.8% and EPS will increase 30.8%.
The average estimate for revenue is $954.8 million. On the bottom line, the average EPS estimate is $0.68.
Last quarter, Mead Johnson Nutrition booked revenue of $921.3 million. GAAP reported sales were 1.3% lower than the prior-year quarter's $933.9 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.71. GAAP EPS of $0.69 for Q3 were 1.4% lower than the prior-year quarter's $0.70 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 61.2%, 40 basis points worse than the prior-year quarter. Operating margin was 21.5%, 150 basis points worse than the prior-year quarter. Net margin was 15.2%, 30 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $3.88 billion. The average EPS estimate is $3.04.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 80 members out of 96 rating the stock outperform, and 16 members rating it underperform. Among 33 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 26 give Mead Johnson Nutrition a green thumbs-up, and seven give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Mead Johnson Nutrition is outperform, with an average price target of $80.36.
Selling to fickle consumers is a tough business for Mead Johnson Nutrition or anyone else in the space. But some companies are better equipped to face the future than others. In a new report, we'll give you the rundown on three companies that are setting themselves up to dominate retail. Click here for instant access to this free report.
- Add Mead Johnson Nutrition to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.